Mechanisms of long COVID and the path toward therapeutics
Cell · 2024-10 · 187 (20) · 5500-5529
DOI: 10.1016/j.cell.2024.07.054 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cell, 2024-10. Verfasst von Michael J Peluso und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, USA. Electronic address: micha…. Hauptthemen laut MEDLINE: COVID-19, Post-Acute COVID-19 Syndrome, SARS-CoV-2. Die Arbeit wurde bisher 384-mal zitiert (Crossref) und nennt 315 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NINDS NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Long COVID, a type of post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (PASC) defined by medically unexplained symptoms following infection with SARS-CoV-2, is a newly recognized infection-associated chronic condition that causes disability in some people. Substantial progress has been made in defining its epidemiology, biology, and pathophysiology. However, there is no cure for the tens of millions of people believed to be experiencing long COVID, and industry engagement in developing therapeutics has been limited. Here, we review the current state of knowledge regarding the biology and pathophysiology of long COVID, focusing on how the proposed mechanisms explain the physiology of the syndrome and how they provide a rationale for the implementation of a broad experimental medicine and clinical trials agenda. Progress toward preventing and curing long COVID and other infection-associated chronic conditions will require deep and sustained investment by funders and industry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, USA. Electronic address: michael.peluso@ucsf.edu.
- Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, USA. Electronic address: steven.deeks@ucsf.edu.
Förderung
- NIAID NIH HHS
- NINDS NIH HHS
- National Institute of Allergy and Infectious Diseases
- National Institute of Neurological Disorders and Stroke
- National Institutes of Health
- Pfizer
Zitieren
APA
Peluso, M. J., & Deeks, S. G. (2024). Mechanisms of long COVID and the path toward therapeutics. Cell, 187(20), 5500-5529. https://doi.org/10.1016/j.cell.2024.07.054
Vancouver
Peluso MJ, Deeks SG. Mechanisms of long COVID and the path toward therapeutics. Cell. 2024;187(20):5500-5529. doi:10.1016/j.cell.2024.07.054
BibTeX
@article{Peluso2024,
author = {Peluso, Michael J and Deeks, Steven G},
title = {Mechanisms of long COVID and the path toward therapeutics},
journal = {Cell},
year = {2024},
volume = {187},
number = {20},
pages = {5500--5529},
doi = {10.1016/j.cell.2024.07.054}
}
EUVIMED